Object Details
- Genentech, Inc.
- Novartis Vaccines and Diagnostics Limited
- Description (Brief)
- (From box)
- For subcutaneous use
- (From insert)
- Xolair is indicated for:
- -Moderate to severe persistent asthma in patients with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids.
- Important Limitations of use:
- -Not indicated for other allergic conditions
- -Not indicated for acute bronchospasm or status asthmaticus
- -Not indicated for pediatric patients less than 12 years of age
- Location
- Currently not on view
- Credit Line
- Gift of Genentech, Inc.
- ca 2013
- product expiration date
- 2016-08
- ID Number
- 2013.0069.13
- catalog number
- 2013.0069.13
- accession number
- 2013.0069
- Object Name
- pharmaceutical
- biological
- Physical Description
- glass (overall material)
- metal (overall material)
- plastic (overall material)
- paper (overall material)
- cardboard (overall material)
- Omalizumab, 150mg (overall ingredient)
- Measurements
- overall: 1 in x 2 1/8 in x 3 3/8 in; 2.54 cm x 5.3975 cm x 8.5725 cm
- bottle of sterile water for injection: 2 3/16 in x 1 in; 5.55625 cm x 2.54 cm
- 10ml syringe: 1 7/8 in x 8 1/4 in x 3/4 in; 4.7625 cm x 20.955 cm x 1.905 cm
- alcohol wipe: 2 in x 2 in; 5.08 cm x 5.08 cm
- overall: 3 3/8 in x 2 in x 1 in; 8.5725 cm x 5.08 cm x 2.54 cm
- place made
- United States: California, South San Francisco
- Switzerland
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- The Antibody Initiative
- Antibody Initiative: Monoclonal Antibodies
- National Museum of American History
- Record ID
- nmah_1445213
- GUID (Link to Original Record)
- http://n2t.net/ark:/65665/ng49ca746ad-e4b7-704b-e053-15f76fa0b4fa
